Evidence that the immunopathogenic mechanism of lithium-induced psoriasis differs from that of regular psoriasis

Bipolar Disord. 2005 Aug;7(4):388-9. doi: 10.1111/j.1399-5618.2005.00214.x.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Antipsychotic Agents / adverse effects*
  • Bipolar Disorder / drug therapy*
  • Female
  • Humans
  • Interleukin-1 / metabolism*
  • Interleukin-6 / metabolism*
  • Lithium Chloride / adverse effects*
  • Male
  • Middle Aged
  • Psoriasis / chemically induced*
  • Psoriasis / immunology*
  • Tumor Necrosis Factor-alpha / metabolism*

Substances

  • Antipsychotic Agents
  • Interleukin-1
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Lithium Chloride